BioCentury
ARTICLE | Company News

PharmAthene other news

August 22, 2011 7:00 AM UTC

PharmAthene received an 18-month, $5.7 million contract under a U.S. Department of Defense Board Agency announcement to develop a mammalian cell-based manufacturing system for the biotech's rBChE pro...